<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/539995</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T13:26:39.000Z</news:publication_date>
      <news:title>FTC and states seek contempt order against Martin Shkreli for breaching pharma work ban</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539996</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T13:17:57.000Z</news:publication_date>
      <news:title>Radical Numerics aims to develop general biological intelligence, says CEO Eric Nguyen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539975</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T13:11:53.000Z</news:publication_date>
      <news:title>Zealand Pharma to invest up to $1.2 billion in Generate’s AI platform for obesity drug development</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539783</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T12:30:21.000Z</news:publication_date>
      <news:title>Vir Biotechnology signs $65M upfront deal with Gilead for solid tumor T-cell engager</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539719</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T12:17:35.000Z</news:publication_date>
      <news:title>Sanofi avoids fine as EU ends antitrust probe over alleged disparagement of rival flu vaccine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539551</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T11:53:49.000Z</news:publication_date>
      <news:title>Study explores how GLP-1 weight-loss drugs affect criminal justice involvement, job prospects and housing stability</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/123087</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T11:31:00.000Z</news:publication_date>
      <news:title>BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539507</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T11:30:27.000Z</news:publication_date>
      <news:title>Arrowhead’s RNA drug cuts Alzheimer’s tau protein in early human study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/538247</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T11:22:31.000Z</news:publication_date>
      <news:title>Alnylam shares tumble to $250 after cutting full-year revenue guidance for its TTR franchise</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539508</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T11:21:47.000Z</news:publication_date>
      <news:title>Zealand Pharma signs up to $1.3 billion AI partnership with Generate Biomedicines for protein-based obesity drugs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539339</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T10:41:26.000Z</news:publication_date>
      <news:title>GSK to cut up to 1,200 jobs in Belgium as part of cost-cutting plan</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539195</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T09:44:02.000Z</news:publication_date>
      <news:title>J&amp;J Q3 earnings fall short of expectations as stock slides, BMS reports mixed trial outcomes and RevMed highlights subgroup data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539047</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T08:30:00.000Z</news:publication_date>
      <news:title>Doctors, hospitals and insurers lobby states on medical AI regulation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539048</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T08:30:00.000Z</news:publication_date>
      <news:title>States could counter potential Trump administration vaccine shortages by producing vaccines themselves</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539049</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T08:30:00.000Z</news:publication_date>
      <news:title>Early-life gut microbiome may influence lifelong brain health, experts say</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539314</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T06:39:00.000Z</news:publication_date>
      <news:title>GSK to cut up to 1,217 jobs in Belgium as cost-saving plan accelerates</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/538248</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T04:30:00.000Z</news:publication_date>
      <news:title>European biotech CEOs divided on whether US or China will lead future partnership deals, Europe seen as lagging</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/538978</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T04:09:00.000Z</news:publication_date>
      <news:title>Zealand Pharma partners with Generate Biomedicines on multispecific obesity proteins in $1.2B deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/538249</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T04:01:00.000Z</news:publication_date>
      <news:title>Jazz CEO urges industry to boost gender diversity in biopharma leadership</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/500951</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T04:00:00.000Z</news:publication_date>
      <news:title>BD and CareFusion recall Alaris Pump infusion sets due to serious performance risks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/538810</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T03:36:00.000Z</news:publication_date>
      <news:title>Agilent to acquire digital pathology software firm Proscia for $240 million upfront</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536895</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T21:00:00.000Z</news:publication_date>
      <news:title>Connectivity in fluid management systems key to reducing process variability</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536727</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T20:35:00.000Z</news:publication_date>
      <news:title>Paragon spinout Velaris Therapeutics goes public via reverse merger with Alaunos, raising $350 million</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536707</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T20:25:40.000Z</news:publication_date>
      <news:title>BlackRock to acquire majority stake in Humana’s CenterWell clinics for $2.8 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539758</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T20:14:00.000Z</news:publication_date>
      <news:title>Gilead signs $1.9 billion deal with Vir Biotechnology to license dual-masked T-cell engagers for oncology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536495</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T19:04:39.000Z</news:publication_date>
      <news:title>FTC and seven states seek contempt order against Martin Shkreli for breaching lifetime pharma ban</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536327</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T18:51:04.000Z</news:publication_date>
      <news:title>Novartis secures supplemental FDA approval to market repurposed antibiotic Lamprene in the US</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536371</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T18:11:36.000Z</news:publication_date>
      <news:title>Veteran infectious disease journalist Helen Branswell dies at 69</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536095</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T18:00:13.000Z</news:publication_date>
      <news:title>Study finds nearly 40% of FDA advisory panels include reps linked to pharma-funded advocacy groups</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536051</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T17:42:27.000Z</news:publication_date>
      <news:title>Verdiva Bio halts mid-stage obesity trial of its GLP-1 pill, citing market evolution</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535883</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T16:54:10.000Z</news:publication_date>
      <news:title>Soufflé Therapeutics raises $135 million to develop three RNA medicines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535947</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T16:24:00.000Z</news:publication_date>
      <news:title>BioNTech&apos;s mRNA cancer therapy fails to improve progression-free survival in head-neck cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535927</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T16:07:06.000Z</news:publication_date>
      <news:title>North Carolina public worker health plan faces court challenge over provider restrictions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535779</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T15:49:00.000Z</news:publication_date>
      <news:title>Roche signs $1 billion deal with China’s Rona Therapeutics for RNAi obesity drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535759</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T15:43:56.000Z</news:publication_date>
      <news:title>Doctors donate heavily to fellow physicians running for office amid Medicare overhaul debate</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535715</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T15:37:36.000Z</news:publication_date>
      <news:title>Beam Therapeutics reports early Phase 1/2 data for base editing therapy in GSD Ia, partners with Pfizer and Enodia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535739</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T15:20:01.000Z</news:publication_date>
      <news:title>J&amp;J’s innovative medicines carried Q3 as medtech disappoints, but newer medicines absent</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535740</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T15:00:29.000Z</news:publication_date>
      <news:title>BioNTech&apos;s head and neck cancer mRNA vaccine fails to extend progression-free survival in Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535547</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T15:00:01.000Z</news:publication_date>
      <news:title>Rudy Tanzi says he may be nearing a cheap, safe Alzheimer’s prevention pill</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535548</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T14:59:28.000Z</news:publication_date>
      <news:title>BioNTech&apos;s head and neck cancer vaccine fails to meet first primary endpoint in pivotal trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535549</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T14:56:16.000Z</news:publication_date>
      <news:title>Health tech firms expand AI scribing tools toward prescribing and billing functions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535591</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T14:31:08.000Z</news:publication_date>
      <news:title>FTC and seven states seek contempt order against Martin Shkreli for breaching pharma work ban</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535571</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T14:27:21.000Z</news:publication_date>
      <news:title>Roche expands obesity R&amp;D footprint with Rona deal worth $1B+</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/539762</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T13:53:00.000Z</news:publication_date>
      <news:title>Stryker invests $400 million in CMR Surgical, securing exclusive U.S. rights to Versius robotic platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535423</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T13:29:22.000Z</news:publication_date>
      <news:title>Patient advocates and experts raise alarm over safety of Neurocrine Biosciences rare disease drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535424</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T13:13:25.000Z</news:publication_date>
      <news:title>Lancet study assesses performance of Google’s diagnostic chatbot AMIE</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535379</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T13:00:59.000Z</news:publication_date>
      <news:title>Readily secures $11 million to expand AI compliance platform for insurers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535235</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T12:55:29.000Z</news:publication_date>
      <news:title>Syndax halts Niktimvo trial for idiopathic pulmonary fibrosis after mid-stage failure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535236</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T12:09:59.000Z</news:publication_date>
      <news:title>Pfizer strikes over $500M partnership with Enodia to develop Sec61-targeting small-molecule drugs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535087</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T11:46:54.000Z</news:publication_date>
      <news:title>Trump administration proposes $70,000 fee to curb foreign student work authorizations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535043</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T11:00:48.000Z</news:publication_date>
      <news:title>Paragon Labs launches ninth biotech, Velaris Therapeutics, via reverse merger to bring cardiopulmonary drugs to Alaunos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535044</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T11:00:35.000Z</news:publication_date>
      <news:title>Former Apogee Therapeutics leaders join Paragon Labs to expand R&amp;D and company creation platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534791</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T10:34:16.000Z</news:publication_date>
      <news:title>Analysts focus on RevMed pancreatic cancer launch and Merck data push ahead of Q3 earnings</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534767</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T10:25:02.000Z</news:publication_date>
      <news:title>Syndax halts development of Niktimvo after Phase 2 failure in IPF trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534768</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T10:19:03.000Z</news:publication_date>
      <news:title>Roche signs $1.2 bn obesity partnership with China&apos;s Rona Therapeutics, paying up to $100 m upfront</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535354</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T08:49:00.000Z</news:publication_date>
      <news:title>BioNTech’s mRNA cancer vaccine misses key endpoint in head-and-neck trial, study to continue</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535355</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T08:46:00.000Z</news:publication_date>
      <news:title>Paragon Labs hires former Apogee leadership after AbbVie acquisition and spins out hypertension unit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534477</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T08:30:00.000Z</news:publication_date>
      <news:title>Physicians Face Learned Helplessness From Training Culture, Says STAT+ Columnist</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534475</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T08:30:00.000Z</news:publication_date>
      <news:title>Botched lethal injection of Christa Pike raises questions about execution protocols</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534476</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T08:30:00.000Z</news:publication_date>
      <news:title>Safety concerns rise as Neurocrine&apos;s Prader-Willi drug linked to deaths and hospitalizations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535018</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T07:16:00.000Z</news:publication_date>
      <news:title>Roche licenses Rona&apos;s ALK7 obesity candidate in $1.2 billion deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536154</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T04:00:00.000Z</news:publication_date>
      <news:title>Medline pulls convenience kits containing recalled BD ChloraPrep applicators due to contamination risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/534406</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T03:24:00.000Z</news:publication_date>
      <news:title>Nurix halts development of BTK degrader zelebrudomide after phase 1 review</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/535858</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T01:42:00.000Z</news:publication_date>
      <news:title>Insulet launches full U.S. release of Omnipod Discover data platform for Omnipod 5 users</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/537074</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00.000Z</news:publication_date>
      <news:title>Study urges regulators to adopt cloud platforms to speed drug approvals</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/537073</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00.000Z</news:publication_date>
      <news:title>Stakeholders urge FDA to adopt flexible approach for psychedelic drug regulation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/536569</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T00:00:00.000Z</news:publication_date>
      <news:title>Roche signs $1.2B partnership with China’s Rona for obesity drug as Stryker pours $400M into CMR Surgical</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/532431</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T21:26:00.000Z</news:publication_date>
      <news:title>First Tracks reports positive early-stage results for celiac drug ANB033</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/531943</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T18:18:36.000Z</news:publication_date>
      <news:title>Merck&apos;s diabetic eye-disease drug hits primary goal but faces commercial doubts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/531775</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T17:08:13.000Z</news:publication_date>
      <news:title>Asahi Kasei Therapeutics receives FDA approval for HSV drug acquired in $1 billion deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/531671</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T15:58:00.000Z</news:publication_date>
      <news:title>Aspen Neuroscience files for Nasdaq IPO to fund Parkinson’s cell therapy program</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/531415</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T15:35:00.000Z</news:publication_date>
      <news:title>Bristol Myers&apos; lung drug admilparant meets Phase 3 goal at low dose, high dose falls short</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/531351</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T15:12:41.000Z</news:publication_date>
      <news:title>Mirum&apos;s Livmarli cuts itching in ultra-rare liver disease trial, showing significant benefit</news:title>
    </news:news>
  </url>
</urlset>
